Arecoline-induced death of human leukemia K562 cells is associated with surface up-modulation of TNFR2

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 2240-2251

  Chen, Ying Jung ^a   Chang, Long Sen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ARECOLINE; CALCIUM ION; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN ADAM17; RECEPTOR ANTIBODY; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL STRAIN K 562; CELL SURFACE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ADAM PROTEINS; ANTHRACENES; ARECOLINE; CALCIUM; CELL DEATH; CHELATING AGENTS; CHOLINERGIC AGONISTS; EGTAZIC ACID; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; K562 CELLS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA INTERFERENCE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84862927515     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22963     Document Type: Article

References (46)

1. Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3: 745-756.
2. 3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model. J Pharmacol Sci 116: 81-88.
3. Cabadak H, Kuçukibrahimoglu E, Aydin B, Kan B, Zafer Goren M. 2009. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line. Auton Autacoid Pharmacol 29: 109-115.
4. Cabadak H, Aydin B, Kan B. 2011. Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol. J Recept Signal Transduct Res 31: 26-32.
5. + T regulatory cells: Applicability to tumor-infiltrating T regulatory cells. J Immunol 180: 6467-6471.
6. Chen YJ, Liu WH, Kao PH, Wang JJ, Chang LS. 2010. Involvement of p38 MAPK- and JNK-modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9-induced apoptosis of human leukemia K562cells. Toxicon 55: 1306-1316.
7. Dasgupta R, Saha I, Pal S, Bhattacharyya A, Sa G, Nag TC, Das T, Maiti BR. 2006. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicol 227: 94-104.
8. Deng YT, Chen HM, Cheng SJ, Chiang CP, Kuo MY. 2009. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin. Oral Oncol 45: e99-e105.
9. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R. 2003. Tumor necrosis factor α converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 270: 2386-2393.
10. Faustman D, Davis M. 2010. TNF receptor 2 pathway: Drug target for autoimmune diseases. Nat Rev Drug Discov 9: 482-493.
11. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA, Wajant H. 2002. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 115: 2757-2770.
12. Fujii T, Kawashima K. 2000. Calcium signaling and c-Fos gene expression via M3 muscarinic acetylcholine receptors in human T- and B-cells. Jpn J Pharmacol 84: 124-132.
13. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P. 1995. The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80kDa tumor-necrosis-factor receptor. Cell 83: 793-802.
14. Guicciardi ME, Gores GJ. 2009. Life and death by death receptors. FASEB J 23: 1625-1637.
15. Hamilton SE, Nathanson NM. 2001. The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J Biol Chem 276: 15850-15853.
16. Ho TJ, Chiang CP, Hong CY, Kok SH, Kuo YS, Kuo MYP. 2000. Induction of the c-jun protooncogene expression by areca nut extract and arecoline on oral mucosal fibroblasts. Oral Oncol 36: 432-436.
17. Hsu HJ, Chang KL, Yang YH, Shieh TY. 2001. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases. Kaohsiung J Med Sci 17: 175-182.
18. Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC. 2003. Roles of keratinocyte inflammation in oral cancer: Regulating the prostaglandin E2, interleukin-6 and TNF-α production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24: 1301-1315.
19. 2+ store release pathway. Can J Physiol Pharmacol 88: 439-447.
20. MacEwan DJ. 2002. TNF receptor subtype signalling: Differences and cellular consequences. Cell Signal 14: 477-492.
21. Matthiesen S, Bahulayan A, Holz O, Racke K. 2007. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. Life Sci 80: 2259-2262.
22. Mochizuki S, Okada Y. 2007. ADAMs in cancer cell proliferation and progression. Cancer Sci 98: 621-628.
23. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. 1985. Tobacco-specific and betal nut-specific N-nitroso compounds: Occureence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 6: 295-303.
24. Peiretti F, Canault M, Deprez-Beauclair P, Berthet V, Bonardo B, Juhan-Vague I, Nalbone G. 2003. Intracellular maturation and transport of tumor necrosis factor α converting enzyme. Exp Cell Res 285: 278-285.
25. Pinckard JK, Sheehan KC, Schreiber RD. 1997. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J Biol Chem 272: 10784-10789.
26. Rae C, MacEwan DJ. 2004. Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching. Cell Death Differ 11: S162-S171.
27. Rimmaudo LE, de la Torre E, Sacerdote de Lustig E, Sales ME. 2005. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. Biochem Biophys Res Commun 334: 1359-1364.
28. Saha I, Chatterji U, Chaudhuri-Sengupta S, Nag TC, Nag D, Banerjee S, Maiti BR. 2007. Ultrastructural and hormonal changes in the pineal-testicular axis following arecoline administration in rats. J Exp Zool Part A Ecol Genet Physiol 307: 187-198.
29. Santee SM, Owen-Schaub LB. 1996. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 271: 21151-21159.
30. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteinases: Multidomain proteins with multiple functions. Genes Dev 17: 7-30.
31. Selvan RS, Rao AR. 1993. Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after shoert-term exposure. Immunopharmacol Immunotoxicol 15: 291-305.
32. Shah N, Khurana S, Cheng K, Raufman JP. 2009. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 296: C221-C232.
33. Sipe KJ, Dantzer R, Kelley KW, Weyhenmeyer JA. 1998. Expression of the 75kDa TNF receptor and its role in contact-mediated neuronal cell death. Mol Brain Res 62: 111-121.
34. Soond SM, Everson B, Riches DWH, Murphy G. 2005. ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118: 2371-2380.
35. Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD. 2000. Divergent roles p55 and p57 tumor necrosis factor receptors in the pathogenesis of MOG935-55-induced experimental autoimmune encephalomyelitis. Cell Immunol 205: 24-33.
36. Szlosarek PW, Balkwill FR. 2003. Tumor necrosis factor a: A potential target for the therapy of solid tumours. Lancet Oncol 4: 565-573.
37. Takashiba S, Shapira L, Amar S, van Dyke TE. 1993. Cloning and characterization of human TNFα promoter region. Gene 131: 307-308.
38. Tartaglia LA, Pennica D, Goeddel DV. 1993. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268: 18542-18548.
39. Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, Nalbone G, Peiretti F. 2006. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res 312: 3969-3980.
40. Thangjam GS, Kondaiah P. 2009. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J Periodontal Res 44: 673-682.
41. Tolosa L, Morla M, Iglesias A, Busquets X, Llado J, Olmos G. 2005. IFN-γ prevents TNF-α-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-κB activity. Cell Signal 17: 1333-1342.
42. Tsai YS, Lee KW, Huang JL, Liu YS, Juo SHH, Kuo WR, Chang JG, Lin CS, Jong YJ. 2008. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicol 249: 230-237.
43. Vander B, van Eyk AD, van Wyk CW, Stander IA. 2001. Diffusion of reduced arecoline and arecaidine through human vaginal and buccal mucosa. J Oral Pathol Med 30: 200-205.
44. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331-367.
45. Wang CK, Lee WH, Peng CH. 1997. Contents of phenolics and alkaloids in Areca catechu Linn. during maturation. J Agric Food Chem 45: 1185-1188.
46. Wen XM, Zhang YL, Liu XM, Guo SX, Wang H. 2006. Immune responses in mice to arecoline mediated by lymphocyte muscarinic acetylcholine receptor. Cell Biol Int 30: 1048-1053.